As the Structural Genomics Consortium (SGC) enters its third decade, it is embarking on an ambitious goal: to become the world’s largest generator of open-source protein-ligand data. Recognizing the growing importance of data science in early-stage drug discovery, SGC is launching a new initiative aimed at training the next generation of computational and data scientists.